By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Animal genetics companies MetaMorphix (MMI) and Stirius have teamed to form AquaAnimal Health, a joint venture that will use MMI's biomarker-based technology to sustain certain characteristics in aquaculture animals such as finfish and crustaceans.

Under the agreement, MMI has granted AcquAnimal Health a license to its proprietary Myostatin technology and an option to its Genius Whole Genome System for use in aquaculture applications.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.